Cochrane Abstracts
Photodynamic therapy for neovascular age‐related macular degeneration
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Photodynamic Therapy for Neovascular Age‐related Macular Degeneration." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435312/all/Photodynamic_therapy_for_neovascular_age‐related_macular_degeneration.
Photodynamic therapy for neovascular age‐related macular degeneration. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435312/all/Photodynamic_therapy_for_neovascular_age‐related_macular_degeneration. Accessed November 25, 2024.
Photodynamic therapy for neovascular age‐related macular degeneration. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435312/all/Photodynamic_therapy_for_neovascular_age‐related_macular_degeneration
Photodynamic Therapy for Neovascular Age‐related Macular Degeneration [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 25]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435312/all/Photodynamic_therapy_for_neovascular_age‐related_macular_degeneration.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Photodynamic therapy for neovascular age‐related macular degeneration
ID - 435312
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435312/all/Photodynamic_therapy_for_neovascular_age‐related_macular_degeneration
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
